CSIMarket
 
Conmed Corporation  (NYSE: CNMD)
 
Price: $49.8500 $-0.13 -0.260%
Day's High: $50.19990158081055 Week Perf: -2.5 %
Day's Low: $ 49.23 30 Day Perf: 7.67 %
Volume (M): 288,045 52 Wk High: $ 56.64
Volume (M$): $ 0 52 Wk Avg: $41.91
Open: $49.76 52 Wk Low: $31.44



 Market Capitalization (Millions $) 1,501
 Shares Outstanding (Millions) 30
 Employees 3,900
 Revenues (TTM) (Millions $) 1,372
 Net Income (TTM) (Millions $) 57
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 13

Business Description


Conmed Corporation is a global medical technology company that specializes in the development, manufacturing, and sales of surgical devices and equipment. The company's products are used in surgical procedures across several medical specialties, including orthopedics, gastroenterology, gynecology, respiratory therapy, and cardiology.

Conmed Corporation was founded in 1970 in Utica, New York. The company has since expanded its operations globally with offices throughout North America, Europe, and Asia. Its headquarters are in Utica, New York.

The company's product offerings include a vast range of surgical instruments, electrosurgical systems, patient monitoring equipment, endoscopy equipment, and imaging systems. They aim to develop innovative solutions to address the needs of healthcare professionals around the world.

Conmed is also known for its advanced energy products that are used in surgical procedures. The company's energy products range from generators and surgical instruments to accessories like medical tapes, electrodes, and connectors. Conmed's EDGE Technology is one of the latest advancements in surgical technology, utilizing both radiofrequency and ultrasound energy to deliver precise and efficient results.

In recent years, Conmed has acquired several companies, including SurgiQuest, Buffalo Filter, and Westmed. These acquisitions have allowed the company to expand its product offerings and solidify its position as a major player in the medical technology industry.

In addition to its core product offerings, Conmed also provides educational resources to healthcare professionals through its Clinical Education Department. The department conducts training sessions, seminars, and workshops to help healthcare professionals stay up-to-date on the latest surgical techniques and innovations.

Conmed has received several awards and recognitions for its innovative products, including the Medical Design Excellence Award, the Clinician's Choice Award, and the Frost & Sullivan Product Innovation Award.

The company is committed to sustainability and reducing its environmental impact. Conmed has implemented various initiatives to reduce waste, energy consumption, and greenhouse gas emissions. They also have a program in place for recycling medical devices and instruments.

Overall, Conmed Corporation is a leading medical technology company that continues to drive innovation in the surgical industry. With a wide range of products and a commitment to sustainability, the company is well-positioned for continued growth and success.


   Company Address: 11311 Concept Blvd Largo, 33773 FL
   Company Phone Number: 392-6464   Stock Exchange / Ticker: NYSE CNMD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ATEC        1.41% 
AXGN        3.11% 
EW        0.28% 
IART        1.38% 
ISRG        0.88% 
RVP        0.27% 
• View Complete Report
   



Dividend

CONMED Corporation Declares Steady Dividend Amid Rising Earnings: What's Next for Shareholders,

Published Mon, Aug 12 2024 2:00 PM UTC



CONMED Corporation: A Steady Dividend Policy Amid Rising Earnings
LARGO, Fla. In a significant announcement today, CONMED Corporation (NYSE: CNMD) declared a quarterly cash dividend of $0.20 per share, set to be paid out on October 4, 2024. This decision, made by the Company s Board of Directors, applies to all shareholders on record as of September 16, 2024...

Dividend

CONMED Corporation Announces Dividend and Faces Stock Challenges: A Deep Dive into the Medical Technology Company's Performance.,

Published Sun, Aug 11 2024 5:42 PM UTC

Press Release: CONMED Corporation Announces Quarterly Cash Dividend and Positive Outlook
CONMED Corporation, a leading medical technology company specializing in surgical devices and equipment, has recently declared a quarterly cash dividend of $0.20 per share. This announcement comes as a positive development for the company s shareholders, underscoring its commitment t...

Dividend

CONMED Corporation Announces Quarterly Cash Dividend, Reflecting Strong Financial Performance

Published Tue, Feb 27 2024 9:05 PM UTC



In a recent press release, CONMED Corporation (NYSE: CNMD), a leading medical technology company, has declared a quarterly cash dividend of $0.20 per share. This announcement comes as a testament to the company s robust financial performance and commitment to rewarding its shareholders. With a wide range of surgical devices and equipment for minimally invasive proc...

Dividend

CONMED Corporation: Empowering Shareholders through Dividend Growth and Technological Advancements

Published Tue, Dec 5 2023 9:05 PM UTC


In a recent press release, CONMED Corporation (NYSE: CNMD) announced the declaration of a quarterly cash dividend of $0.20 per share on December 4, 2023. The dividend is scheduled for payment on January 5, 2024, to shareholders of record as of December 18, 2023. This move underscores CONMED s commitment to rewarding its shareholders while highlighting the company s stab...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 26.95
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.09
Price to Sales (Expected) -
Price to Book 1.44
PEG (TTM) -

Financial Strength Current
Quick Ratio -
Working Capital Ratio 1.48
Leverage Ratio (MRQ) 1.87
Total Debt to Equity 1.6
Interest Coverage (TTM) 9.22
Debt Coverage (TTM) 0.19

Per Share Current
Earnings (TTM) 1.85 $
Revenues (TTM) 45.54 $
Cash Flow (TTM) 0.04 $
Cash -
Book Value 34.58 $
Dividend (TTM) 0.4 $

Efficiency Current
Revenue per Employee (TTM) 351,707
Net Income per Employee (TTM) 14,486
Receivable Turnover Ratio (TTM) 5.83
Inventory Turnover Ratio (TTM) 1.68
Asset Turnover Ratio (TTM) 0.59

Profitability Ratios Current
Gross Margin (MRQ) 57.49 %
Operating Margin (MRQ) 10.6 %
Net Margin (MRQ) 6.72 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 32.12 %

Management Effectiveness Current
Return On Assets (TTM) 2.44 %
Return On Investment (TTM) 2.66 %
Return On Equity (TTM) 5.51 %
Dividend Yield 0.8 %
Pay out Ratio (TTM) 32.43 %



Conmed's Segments
Orthopedic Surgery    87.33 % of total Revenue
General Surgery    104.97 % of total Revenue
United States    101.44 % of total Revenue
EMEA    42.3 % of total Revenue
Asia Pacific    28.86 % of total Revenue
Americas (excluding the United States)    19.71 % of total Revenue

  Conmed Outlook

On October 7 2024 the Conmed provided following guidance

nnCONMED Corporation Releases Preliminary Financial Projections for Third Quarter 2024nn

LARGO, Fla. — Following up on its Current Report on Form 8-K issued on September 30, 2024, CONMED Corporation (NYSE: CNMD) has announced preliminary financial estimates for the third quarter of fiscal year 2024. The company anticipates revenues to be between $315 million and $318 million.

In addition, CONMED is projecting that its adjusted diluted net earnings per share will grow at a rate surpassing its prior forecast of 9% to 11%. This upward revision reflects the company’s strong performance during the quarter, underlining its ongoing success and resilience in the medical devices sector.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.